Fumaric Acid

Fumaric Acid

SCHEMBL8866086

COc1ccc(C(C)Cc2ccccc2)cc1OC.N.O=C(O)C=CC(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 1/20 0.44
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
ACHE P22303 1/20 0.49
ALDH1A1 P00352 4/20 0.48
POLB P06746 2/20 0.48
AKR1C3 P42330 1/20 0.47
HIF1A Q16665 1/20 0.47
TAAR1 Q96RJ0 1/20 0.46
LDHA P00338 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
FPR2 P25090 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8976449 0.89 PDE4A (0.51) CA1CA2ACHEHIF1ALDHA
Fumaric Acid SCHEMBL8866054 0.83 PPARG (0.52) ALDH1A1TAAR1LDHAMAPK1KMT2A
Fumaric Acid SCHEMBL8865670 0.82 MTNR1A (0.55) ACHETAAR1
Fumaric Acid SCHEMBL7267617 0.80 TAAR1 (0.58) ALDH1A1AKR1C3TAAR1HPGDCYP2C19
Fumaric Acid SCHEMBL8865834 0.79 TAAR1 (0.48) ALDH1A1AKR1C3TAAR1SMN1; SMN2FPR2
Fumaric Acid SCHEMBL8866467 0.78 TAAR1 (0.52) ACHEALDH1A1AKR1C3TAAR1HPGD
Fumaric Acid SCHEMBL8867436 0.77 TDP1 (0.53) ALDH1A1TAAR1LDHAKMT2AADRB3
Fumaric Acid SCHEMBL8976061 0.77 TAAR1 (0.51) POLBTAAR1
SCHEMBL18252781 0.76 HIF1A (0.52) CA1CA2ACHEHIF1ALDHA
Fumaric Acid SCHEMBL8866895 0.76 HCAR2 (0.49) ALDH1A1AKR1C3TAAR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605916-A Arylalkyl-amines having anticonvulsant and neuroprotective properties ASTRA AB (SE) 1997-02-25 US disclosed
US-5539120-A Arylalkyl-amines having anticonvulsant and neuroprotective properties AGENCE SPATIALE EUROPEENNE (FR) 1996-07-23 US disclosed
EP-0356035-B1 Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties ASTRA AB (SE) 1996-03-13 EP disclosed
EP-0648745-A1 Arylalkylamine having anticonvulsant and neuroprotective properties Astra Aktiebolag (SE) 1995-04-19 EP disclosed
EP-0648489-A1 Arylalkylamides having neuroprotective properties FISONS CORPORATION (US) 1995-04-19 EP disclosed
US-5331007-A Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties FISONS CORPORATION (US) 1994-07-19 US disclosed
WO-1991011995-A1 ARYLALKYL-AMINES AND -AMIDES HAVING ANTICONVULSANT AND NEUROPROTECTIVE PROPERTIES FISONS CORPORATION (US) 1991-08-22 WO disclosed